Aerni Amanda, Traber Rafael, Hock Christoph, Roozendaal Benno, Schelling Gustav, Papassotiropoulos Andreas, Nitsch Roger M, Schnyder Ulrich, de Quervain Dominique J-F
Division of Psychiatry Research, University of Zurich, Lenggstr. 31, 8029 Zurich, Switzerland.
Am J Psychiatry. 2004 Aug;161(8):1488-90. doi: 10.1176/appi.ajp.161.8.1488.
Because elevated cortisol levels inhibit memory retrieval in healthy human subjects, the present study investigated whether cortisol administration might also reduce excessive retrieval of traumatic memories and related symptoms in patients with chronic posttraumatic stress disorder (PTSD).
During a 3-month observation period, low-dose cortisol (10 mg/day) was administered orally for 1 month to three patients with chronic PTSD in a double-blind, placebo-controlled, crossover design.
In each patient investigated, there was a significant treatment effect, with cortisol-related reductions of at least 38% in one of the daily rated symptoms of traumatic memories, as assessed by self-administered rating scales. In accordance, Clinician-Administered PTSD Scale ratings assessed after each month showed cortisol-related improvements for reexperiencing symptoms and, additionally, in one patient for avoidance symptoms.
The results of this pilot study indicate that low-dose cortisol treatment reduces the cardinal symptoms of PTSD.
由于皮质醇水平升高会抑制健康人类受试者的记忆提取,本研究调查了给予皮质醇是否也可能减少慢性创伤后应激障碍(PTSD)患者对创伤性记忆及相关症状的过度提取。
在为期3个月的观察期内,采用双盲、安慰剂对照、交叉设计,对3例慢性PTSD患者口服低剂量皮质醇(10毫克/天),持续1个月。
在每例接受调查的患者中,均有显著的治疗效果,通过自我评定量表评估,与皮质醇相关的创伤性记忆每日评定症状之一至少降低了38%。相应地,每月后进行的临床医生评定的PTSD量表评分显示,与皮质醇相关的再体验症状有所改善,此外,在1例患者中,回避症状也有所改善。
这项初步研究的结果表明,低剂量皮质醇治疗可减轻PTSD的主要症状。